Skip to Content

Zanubrutinib (Brukinsa®) Patient Selection and Management

Download PQI pdf 0.18MB

Last Updated: February 15, 2024

By: Kayla Randle, PharmD, BCOP

About this PQI

The purpose of this PQI is to identify differentiating characteristics which would indicate zanubrutinib as the preferred treatment option in Mantle Cell Lymphoma (MCL) and to discuss key counseling and monitoring criteria to improve patient outcomes.

More About This PQI

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI